Michel Janicot

Biography

 Michel holds a PhD degree in Biochemistry (Molecular and Cellular Biology) from the University of Paris VII (France) and was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). He has over 25 years experience in Oncology preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and Janssen (Johnson & Johnson). Since 2012, Michel is the founder and CEO of JMi ONConsulting, a consulting firm specialized in providing services and guidances for (small molecules and biologicals) R&D programs in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology.  He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology Drug Development. Michel joined InteRNA as Chief Development Officer in 2016.  

Research Interest

 Molecular and Cellular Biology